Metagenomi, Inc. Common Stock
NASDAQ Global SelectTotal Valuation
Metagenomi, Inc. Common Stock carries a market capitalization of 44.05M, placing it among publicly traded companies globally. Its enterprise value stands at -50.53M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 44.05M |
| Enterprise Value | -50.53M |
Share Statistics
Metagenomi, Inc. Common Stock currently has 37.65M shares outstanding.
| Shares Outstanding | 37.65M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 2.24, and the price-to-book ratio stands at 0.37.
| PE Ratio | N/A |
| PS Ratio | 2.24 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.37 |
| P/FCF Ratio | -0.58 |
| P/OCF Ratio | -0.57 |
Financial Position
Metagenomi, Inc. Common Stock maintains a current ratio of 6.43, meaning it holds 6.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.43 |
| Quick Ratio | 6.23 |
| Debt / Equity | 28.44 |
| Debt / EBITDA | -0.45 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -49.02 |
| Return on Assets (ROA) | -34.71 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | -146,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Metagenomi, Inc. Common Stock's stock has declined approximately -34.26966% over the past 52 weeks. The 50-day moving average sits at 1.23, while the 200-day moving average is 1.43.
| Beta (5Y) | N/A |
| 52-Week Price Change | -34.26966% |
| 50-Day Moving Average | 1.23 |
| 200-Day Moving Average | 1.43 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Metagenomi, Inc. Common Stock generated 22.33M in revenue and converted that into -85.89M in net income, yielding earnings per share of -2.30. EBITDA reached -87.55M, while operating income came in at -92.78M.
| Revenue | 22.33M |
| Gross Profit | N/A |
| Operating Income | -92.78M |
| Pretax Income | -86.03M |
| Net Income | -85.89M |
| EBITDA | -87.55M |
| EBIT | -92.78M |
| Earnings Per Share (EPS) | -2.30 |
Balance Sheet
Metagenomi, Inc. Common Stock holds 140.16M in cash and equivalents against 39.19M in total debt, resulting in a net debt position of -25.31M. Total book value stands at 137.79M, with working capital of 122.06M providing operational flexibility.
| Cash & Cash Equivalents | 140.16M |
| Total Debt | 39.19M |
| Net Debt | -25.31M |
| Equity (Book Value) | 137.79M |
| Book Value Per Share | 3.66 |
| Working Capital | 122.06M |
Cash Flow
Metagenomi, Inc. Common Stock produced -87.22M in operating cash flow over the past twelve months. After subtracting -311,000.00 in capital expenditures, free cash flow totaled -87.54M - equivalent to -2.34 per share.
| Operating Cash Flow | -87.22M |
| Capital Expenditures | -311,000.00 |
| Free Cash Flow | -87.54M |
| FCF Per Share | -2.34 |
Margins
Metagenomi, Inc. Common Stock operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -415.48 and net profit margin of -384.61 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -415.48 |
| Pretax Margin | -385.27 |
| Profit Margin | -384.61 |
| EBITDA Margin | -392.04 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.61 |
| FCF Yield | -173.60 |
Scores
Metagenomi, Inc. Common Stock posts an Altman Z-Score of -2.56, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -2.56 |